Cargando…
Neutralizing GM-CSF autoantibodies in pulmonary alveolar proteinosis, cryptococcal meningitis and severe nocardiosis
BACKGROUND: Anti GM-CSF autoantibodies (aAb) have been related to acquired pulmonary alveolar proteinosis (PAP) and described in cases of severe infections such as cryptococcosis and nocardiosis in previously healthy subjects. Whether there are different anti-GM-CSF autoantibodies corresponding to t...
Autores principales: | Salvator, Hélène, Cheng, Aristine, Rosen, Lindsey B., Williamson, Peter R., Bennett, John E., Kashyap, Anuj., Ding, Li, Kwon-Chung, Kyung J., Namkoong, Ho, Zerbe, Christa S., Holland, Steven M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9552154/ https://www.ncbi.nlm.nih.gov/pubmed/36221098 http://dx.doi.org/10.1186/s12931-022-02103-9 |
Ejemplares similares
-
Neutralization and clearance of GM-CSF by autoantibodies in pulmonary alveolar proteinosis
por: Piccoli, Luca, et al.
Publicado: (2015) -
GM-CSF Autoantibody-positive Pulmonary Alveolar Proteinosis with Simultaneous Myeloproliferative Neoplasm
por: Imoto, Naoto, et al.
Publicado: (2017) -
The Role of GM-CSF Autoantibodies in Infection and Autoimmune Pulmonary Alveolar Proteinosis: A Concise Review
por: Ataya, Ali, et al.
Publicado: (2021) -
Proteinosis alveolar. Remisión completa tras tratamiento con GM-CSF inhalado
por: López Monzoni, Sonia, et al.
Publicado: (2022) -
Pulmonary Alveolar Proteinosis Refractory to Plasmapheresis and Rituximab despite GM-CSF Antibody Reduction
por: Keske, Aysenur, et al.
Publicado: (2022)